Trial Profile
Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2019
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms ROPI-POSTOP
- 26 Sep 2019 Status changed from recruiting to completed.
- 03 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 03 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.